Table 2 Lipid profile and plasma ApoA-I concentration in COVID patients and control subjects.

From: Altered high-density lipoprotein composition and functions during severe COVID-19

Lipid profile

Admission (D1)

Day 3

Day 7

Controls

p values

(D1 vs Controls)

TC, mmol/L, median [IQR]

2.65 [2.46–3.88]

2.68 [2.30–3.24]

4.09 [3.21–4.89]

5.25 [4.83–5.73]

0.0016

TG, mmol/L, median [IQR]

2.53 [1.73–2.99]

2.73 [2.0–3.18]

2.11 [2.02–3.60]

1.20 [0.90–1.83]

0.0152

HDL-C, mmol/L, median [IQR]

0.77 [0.49–0.83]

0.58 [0.44–0.86]

0.84 [0.64–0.91]

1.46 [1.34–1.69]

< 0.0001

LDL-C, mmol/L, median [IQR]

1.43 [1.28–2.20]

1.55 [1.13–2.0]

0.96 [0.90–2.19]

3.20 [2.15–3.65]

0.0081

Apo-AI, mg/dL, median [IQR]

48.3 [18.8–53.2]

45.1 [18.6–56.9]

56.9 [48.2–61.6]

92.8 [84.9–103.9]

< 0.0001

  1. Mann–Whitney test was performed to compare the lipid profiles of controls (n = 16) versus COVID-19 at admission (n = 8) patients.
  2. TC, total cholesterol; TG, triglyceride; HDL-C, High-density lipoprotein cholesterol; LDL-C, Low-density lipoprotein cholesterol.
Back to article page